4/18
02:12 pm
tgtx
TG Therapeutics, Inc. (NASDAQ: TGTX) had its "overweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $25.00 price target on the stock.
Low
Report
TG Therapeutics, Inc. (NASDAQ: TGTX) had its "overweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $25.00 price target on the stock.
4/18
02:12 pm
tgtx
TG Therapeutics, Inc. (NASDAQ: TGTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $45.00 price target on the stock.
Low
Report
TG Therapeutics, Inc. (NASDAQ: TGTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $45.00 price target on the stock.
4/18
01:28 pm
tgtx
Rating for TGTX
Low
Report
Rating for TGTX
4/18
01:25 pm
tgtx
Rating for TGTX
Low
Report
Rating for TGTX
2/29
06:08 am
tgtx
Rating for TGTX
Low
Report
Rating for TGTX
2/29
06:08 am
tgtx
Rating for TGTX
Low
Report
Rating for TGTX
2/29
06:08 am
tgtx
Rating for TGTX
Low
Report
Rating for TGTX
2/28
01:10 pm
tgtx
TG Therapeutics, Inc. (NASDAQ: TGTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $45.00 price target on the stock.
Low
Report
TG Therapeutics, Inc. (NASDAQ: TGTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $45.00 price target on the stock.